All Pharma News
Merz Therapeutics Plans US Workforce Growth After $185M Asset Purchase

Merz Therapeutics Plans US Workforce Growth After $185M Asset Purchase
FIERCE PHARMA
12 Jul 2024
Share Share
Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%

Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%
PHARMACEUTICAL-TECHNOLOGY
11 Jul 2024
Share Share
Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics

Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
BUSINESSWIRE
10 Jul 2024
Share Share
Acorda fights on with new Inbrija ad ahead of bankruptcy sale

Acorda fights on with new Inbrija ad ahead of bankruptcy sale
Andrea Park FIERCE PHARMA
04 Jun 2024
Share Share
US FDA declines to approve Supernus` Parkinson`s combination again

US FDA declines to approve Supernus` Parkinson`s combination again
REUTERS
09 Apr 2024
Share Share
Acorda Therapeutics Announces Nasdaq Delisting Notification

Acorda Therapeutics Announces Nasdaq Delisting Notification
BUSINESSWIRE
03 Apr 2024
Share Share
Acorda files for bankruptcy, inks $185M asset deal to Merz

Acorda files for bankruptcy, inks $185M asset deal to Merz
Zoey Becker FIERCE PHARMA
03 Apr 2024
Share Share
Acorda Cancels Q4 and Year End 2023 Earnings Conference Call

Acorda Cancels Q4 and Year End 2023 Earnings Conference Call
BUSINESSWIRE
01 Apr 2024
Share Share
Acorda and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement

Acorda and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
BUSINESSWIRE
01 Apr 2024
Share Share
Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda

Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda
Kevin Dunleavy FIERCE PHARMA
12 Jan 2024
Share Share